Robotic Microtool Control in an Intelligent Automated In Vitro Fertilization and Intracytoplasmic Sperm Injection Platform
US-2024426856-A1 · Dec 26, 2024 · US
Composition for embryo culture
US9410120B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9410120-B2 |
| Application number | US-201214236534-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 18, 2012 |
| Priority date | Aug 3, 2011 |
| Publication date | Aug 9, 2016 |
| Grant date | Aug 9, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided is a composition for embryo culture, which contains a constitution suitable for embryo culture. Provided is a composition for embryo culture, which contains (a) a constitution shown in Table A below. TABLE A Components mM L-Alanine 0.297 ± 0.089 L-Asparagine 0.015 ± 0.005 L-Aspartic acid 0.120 ± 0.036 L-Glutamic acid 0.550 ± 0.165 Glycine 0.979 ± 0.294 L(−)-Proline 0.105 ± 0.032 L-Serine 0.176 ± 0.053 L(+)-Arginine 0.108 ± 0.032 L(−)-Cystine 0.048 ± 0.014 L-Histidine 0.053 ± 0.016 L(+)-Isoleucine 0.036 ± 0.011 L-Leucine 0.081 ± 0.024 L(+)-Lysine 0.176 ± 0.053 L-Methionine 0.022 ± 0.007 L(−)-Phenylalanine 0.045 ± 0.013 L(−)-Threonine 0.109 ± 0.033 L-Tryptophan 0.018 ± 0.005 L-Tyrosine 0.048 ± 0.014 L-Valine 0.108 ± 0.032 L-Glutamine or 0.398 ± 0.119 glutamine derivative Taurine 1.412 ± 0.424
First claim
Opening claim text (preview).
The invention claimed is: 1. A composition for an embryo culture, comprising: a mixture of the components shown in Table A below, the components being present in the concentrations shown in Table A below; and a chelator, TABLE A Components mM L-Alanine 0.297 ± 0.089 L-Asparagine 0.015 ± 0.005 L-Aspartic acid 0.120 ± 0.036 L-Glutamic acid 0.550 ± 0.165 Glycine 0.979 ± 0.294 L(−)-Proline 0.105 ± 0.032 L-Serine 0.176 ± 0.053 L(+)-Arginine 0.108 ± 0.032 L(−)-Cystine 0.048 ± 0.014 L-Histidine 0.053 ± 0.016 L(+)-Isoleucine 0.036 ± 0.011 L-Leucine 0.081 ± 0.024 L(+)-Lysine 0.176 ± 0.053 L-Methionine 0.022 ± 0.007 L(−)-Phenylalanine 0.045 ± 0.013 L(−)-Threonine 0.109 ± 0.033 L-Tryptophan 0.018 ± 0.005 L-Tyrosine 0.048 ± 0.014 L-Valine 0.108 ± 0.032 L-Glutamine or glutamine 0.398 ± 0.119 derivative Taurine 1.412 ± 0.424. 2. The composition for an embryo culture according to claim 1 , further comprising electrolytes. 3. The composition for an embryo culture according to claim 2 , further comprising organic acids and/or carbohydrates. 4. The composition for an embryo culture according to claim 3 , further comprising at least one component selected from the group consisting of pH indicators, pH adjusters, pH buffers, antibiotics, vitamins, trace metal elements, hormones, growth factors, lipids or constituents thereof, carrier proteins, extracellular matrix components, reducing substances and polymers. 5. The composition for an embryo culture according to claim 1 , wherein the glutamine derivative is glycyl-L-glutamine, L-alanyl-L-glutamine, L-leucyl-L-glutamine, L-valyl-L-glutamine or L-isoleucyl-L-glutamine. 6. The composition for an embryo culture according to claim 1 , wherein the chelator is at least one selected from the group consisting of ethyleneglycol bis tetraacetic acid, ethylene diamine tetraacetic acid, ethylene diamine diacetic acid and diethylene triamine pentaacetic acid. 7. The composition for an embryo culture according to claim 1 , wherein the composition is in the form of a sterile solution, a sterile concentrated solution or a sterile lyophilized product.
Assignees
Inventors
Classifications
- C12N5/0604Primary
Whole embryos; Culture medium therefor · CPC title
Amino acids · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9410120B2 cover?
- Provided is a composition for embryo culture, which contains a constitution suitable for embryo culture. Provided is a composition for embryo culture, which contains (a) a constitution shown in Table A below. TABLE A …
- Who is the assignee on this patent?
- Yao Tatsuma, Asayama Yuta, Matsuhisa Akio, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification C12N5/0604. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).